loadpatents
name:-0.026173830032349
name:-0.012176990509033
name:-0.0033090114593506
MATSUI; Junji Patent Filings

MATSUI; Junji

Patent Applications and Registrations

Patent applications and USPTO patent grants for MATSUI; Junji.The latest application filed is for "linear motion guide unit".

Company Profile
4.20.33
  • MATSUI; Junji - Mino-shi JP
  • Matsui; Junji - Tsukuba JP
  • MATSUI; Junji - Tsukuba-shi JP
  • Matsui; Junji - Ibaraki N/A JP
  • Matsui; Junji - Toride N/A JP
  • Matsui; Junji - Toride-shi JP
  • Matsui; Junji - Osaka JP
  • Matsui, Junji - Osaka-shi JP
  • Matsui, Junji - Ichihara-shi JP
  • Matsui, Junji - Osaka-shi Osaka JP
  • Matsui; Junji - Tokyo JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Linear Motion Guide Unit
App 20220186779 - MATSUI; Masashi ;   et al.
2022-06-16
Combination of a PD-1 antagonist and eribulin for treating cancer
Grant 10,945,990 - Matsui , et al. March 16, 2
2021-03-16
Method for Predicting Effectiveness of Angiogenesis Inhibitor
App 20200199689 - Semba; Taro ;   et al.
2020-06-25
Method for Inhibiting Tumor Growth
App 20190111022 - Asano; Makoto ;   et al.
2019-04-18
Tumor Therapeutic Agent
App 20190000797 - Okamoto; Kiyoshi ;   et al.
2019-01-03
Therapeutic Agent For Biliary Tract Cancer
App 20190000829 - Matsui; Junji ;   et al.
2019-01-03
Biomarkers For Predicting And Assessing Responsiveness Of Thyroid And Kidney Cancer Subjects To Lenvatinib Compounds
App 20180209980 - Funahashi; Yasuhiro ;   et al.
2018-07-26
Anti human Notch4 antibody
Grant 9,969,812 - Sakamoto , et al. May 15, 2
2018-05-15
Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds
Grant 9,945,862 - Funahashi , et al. April 17, 2
2018-04-17
Combination Of A Pd-1 Antagonist And Eribulin For Treating Cancer
App 20180071247 - MATSUI; Junji ;   et al.
2018-03-15
Method For Predicting Effectiveness Of Angiogenesis Inhibitor
App 20170191137 - Semba; Taro ;   et al.
2017-07-06
Use Of Eribulin In The Treatment Of Cancer
App 20170100367 - ASANO; Makoto ;   et al.
2017-04-13
Anti Human Notch4 Antibody
App 20170096493 - Sakamoto; Yoshimasa ;   et al.
2017-04-06
Anti human Notch4 antibody
Grant 9,527,921 - Sakamoto , et al. December 27, 2
2016-12-27
Anti Human Notch4 Antibody
App 20160347858 - Sakamoto; Yoshimasa ;   et al.
2016-12-01
Antitumor agent for thyroid cancer
Grant 9,006,256 - Matsui April 14, 2
2015-04-14
Method for assay on the effect of vascularization inhibitor
Grant 9,006,240 - Uenaka , et al. April 14, 2
2015-04-14
Method for assay on the effect of vascularization inhibitor
Grant 8,969,344 - Matsui , et al. March 3, 2
2015-03-03
Therapeutic agent for tumor
Grant 8,962,650 - Narita , et al. February 24, 2
2015-02-24
Biomarkers For Predicting And Assessing Responsiveness Of Thyroid And Kidney Cancer Subjects To Lenvatinib Compounds
App 20140187577 - Funahashi; Yasuhiro ;   et al.
2014-07-03
Method For Predicting Effectiveness Of Angiogenesis Inhibitor
App 20140148483 - Semba; Taro ;   et al.
2014-05-29
Therapeutic Agent For Tumor
App 20140031384 - Narita; Yusuke ;   et al.
2014-01-30
Method For Assay On The Effect Of Vascularization Inhibitor
App 20130085152 - Matsui; Junji ;   et al.
2013-04-04
Nitrogen-containing aromatic derivatives
Grant 8,372,981 - Funahashi , et al. February 12, 2
2013-02-12
Antitumor Agent For Thyroid Cancer
App 20110207756 - Matsui; Junji
2011-08-25
Nitrogen-containing aromatic derivatives
Grant 7,973,160 - Funahashi , et al. July 5, 2
2011-07-05
Nitrogen-containing Aromatic Derivatives
App 20110118470 - FUNAHASHI; Yasuhiro ;   et al.
2011-05-19
Nitrogen-Containing Aromatic Derivatives
App 20100197911 - Funahashi; Yasuhiro ;   et al.
2010-08-05
Method For Prediction Of The Efficacy Of Vascularization Inhibitor
App 20100105031 - Matsui; Junji ;   et al.
2010-04-29
Method For Assay On The Effect Of Vascularization Inhibitor
App 20100092490 - Uenaka; Toshimitsu ;   et al.
2010-04-15
Aromatic amine derivative and use thereof
App 20090325956 - Taniguchi; Takahiko ;   et al.
2009-12-31
Nitrogen-containing aromatic derivatives
Grant 7,612,092 - Funahashi , et al. November 3, 2
2009-11-03
Antitumor Agent For Thyroid Cancer
App 20090209580 - Matsui; Junji
2009-08-20
Facsimile apparatus
Grant 7,292,362 - Matsuda , et al. November 6, 2
2007-11-06
Nitrogen-containing aromatic derivatives
Grant 7,253,286 - Funahashi , et al. August 7, 2
2007-08-07
Nitrogen-containing aromatic derivatives
App 20060247259 - Funahashi; Yasuhiro ;   et al.
2006-11-02
Nitrogen-containing aromatic derivatives
App 20060160832 - Funahashi; Yosuhiro ;   et al.
2006-07-20
Beta secretase inhibitors
App 20050228020 - Miyamoto, Masaomi ;   et al.
2005-10-13
Facsimile apparatus
App 20050179957 - Matsuda, Hirofumi ;   et al.
2005-08-18
Method for reproducing lithium sulfide and method for producing polyarylene sulfide
App 20050118093 - Senga, Minoru ;   et al.
2005-06-02
-Secretase inhibitors
App 20040110743 - Miyamato, Masaomi ;   et al.
2004-06-10
Nitrogen-containing aromatic derivatives
App 20040053908 - Funahashi, Yasuhiro ;   et al.
2004-03-18
Apoptosis inhibitor
App 20020086883 - Matsui, Junji ;   et al.
2002-07-04
Soft x-ray source and method for manufacturing the same
Grant 4,238,706 - Yoshihara , et al. December 9, 1
1980-12-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed